Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years
Further incretin-based drug development For both GIP and GLP-1, positive effects were also observed on cardiovascular complications [23], indicating a therapeutic potential beyond the improvement of diabetes complications
Potential therapeutic applications of mnSODs and SOD-mimetics
In IV drip contents, L-carnitine appears in performance and athletic recovery formulas, fatigue protocols, and some weight-management treatments
Key takeaways What it is: A compounded injectable blend, typically GHK-Cu + glutathione + ascorbic acid, marketed for skin rejuvenation under brand names including GLOW and Klow